Clinical Trial

Digital Tool for Psychological Support in Women With Breast Cancer

Study acronym: SerenApp
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 11, 2025 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study will design, test, and evaluate SerenApp, a digital health tool created to support women after completing treatment for breast cancer. Many women live for many years after breast cancer, but a large number continue to experience emotional difficulties such as anxiety, sadness, stress, or fear of the cancer coming back. These problems can strongly affect quality of life and are often not addressed during routine medical visits. SerenApp is being developed as a safe, easy-to-use mobile application that provides psychological support and practical resources to help breast cancer survivors manage these challenges. What makes this project different is that the app will be created together with patients and healthcare professionals, to ensure that it responds to real needs and is adapted to the public health system in Spain. The main questions of the study are: Can SerenApp help women feel less anxious, depressed, or stressed and improve their overall quality of life? Will women and professionals find the app useful, acceptable, and easy to use? Could this digital tool reduce the need for additional healthcare resources and be cost-effective for the health system?
Trial Details
NCT Number NCT07169539
Lead Sponsor Hospital Costa del Sol
Conditions Breast Cancer
Enrollment 90 participants
Start Date 2025-10-01
Primary Completion 2026-03-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-11